Skip navigation
Agenda

Real-Time Policy Briefings, Impactful Managed Market Trends and Strategies to Ensure Product Access

August 13-14, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, AUGUST 13, 2019

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

8:45

STATE OF THE INDUSTRY Political and Legislative Trends Impacting Healthcare Coverage and Access

Christina Sandefur
Executive Vice President
Goldwater Institute

9:30

The Current State of Safe Harbor Protection for Rebates — Where Are We Now?

Ross Margulies
Associate
Foley Hoag LLP

10:15

Networking and Refreshment Break

10:45

PANEL Realign Access Strategies to Overcome Challenges of Copay Assistance and PBM Restrictions

PANELISTS:

Stacey Worthy
Counsel
Aimed Alliance

Kollet Koulianos, MBA
Senior Director, Payer Relations
National Hemophilia Foundation

Christina Simmons
Senior Corporate Counsel
Pfizer Inc

Saiza Elayda, J.D.
Director, State and Policy
PhRMA

11:30

COMPLIANCE SPOTLIGHT Trends in Enforcement and Oversight — What Companies Can Do to Ensure Compliance

PANELISTS:

Anthony Scicchitano
Assistant U.S. Attorney
U.S. Attorney’s Office for the Eastern District of Pennsylvania

Jacob Elberg
Associate Professor
Seton Hall University School of Law

12:15

Networking Luncheon

1:30

Outsource vs. Insource — Strategies and Considerations for Vendor Management

Colette Flack
Senior Director, Patient Support Services,
Dermira

2:15

PANEL Manufacturer Spotlight — Forward-Thinking Strategies to Ensure Market Access and Adherence

MODERATOR:

William Daniels
Director, Business and Market Segment Development
Conduent

PANELISTS:

Douglas Neely, CMPE
Head, Global Market Access
Athenex Oncology

Tony Tipton
Senior Director, Managed Markets and Trade Channels
Eyevance Pharmaceuticals

Gergana Zlateva
Vice President, Payer Insights and Access
Pfizer Inc

3:00

Networking and Refreshment Break

3:30 CHOOSE BETWEEN TWO SUMMITS (1-2)

1 Medicare and Marketplace Coverage Policies Impacting Access

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals;
former Director, Healthcare Policy and Federal Programs
BIO

2 Medical Device Coverage and Reimbursement

Timothy Kringel
Senior Vertical Solutions Consultant
LexisNexis Risk Solutions

4:30CHOOSE BETWEEN TWO SUMMITS (3-4)

3 New Product Commercialization/Launch
Scenario Planning

Jeff Henderson
Vice President, Head of Market Access and Government Affairs
Sobi, Inc.

Tami Carten
Executive Director, Market Access
Braeburn

4 Patient Assistance Compliance and Oversight

Rujul Desai
Of Counsel
Covington & Burling LLP

5:00

Close of Summits and Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO WEDNESDAY, AUGUST 14, 2019

8:00

Networking Breakfast

8:30

Conference Chairman’s Review of Day One

8:45

Changing Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and Pharmacy

Jesse C. Dresser, Esq.
Partner
Frier Levitt, LLC

9:30

Trends in Benefit Design and the Continued Shift to High Deductible Plans

Gregory Gierer
Senior Vice President, Policy
America’s Health Insurance Plans (AHIP)

Alex Keeton
Director, Policy Research and Analytics
BIO

10:15

Pathways to Improvement — Insight on Achieving a Value-Driven, Transparent and Affordable Healthcare System

J. Gabriel McGlamery, J.D.
Senior HCR Policy Consultant
Florida Blue

11:00

Networking and Refreshment Break

11:30

CHOOSE BETWEEN TWO TOPIC INTENSIVES (A-B)

A Paving the Way for Global Access and Commercialization

Stuart Bell
Vice President Consulting, Medicines Access
Inceptua Ltd

BBiosimilar Policy Evolution and Access Strategy

Molly Burich, MS
Director, Public Policy – Biosimilars and Reimbursement
Boehringer Ingelheim

12:15

Networking Luncheon

CHOOSE BETWEEN TWO TOPIC INTENSIVES (C-D)

C The Role and Growing Use of Digital Therapeutics by Payers, IDNs and Health Systems

Everett Crosland
Vice President, Market Access, Reimbursement and Government Affairs
AppliedVR

Andy Molnar
Senior Director, Market Access
Cognoa

DBuilding Value and Establishing Market Access C Pathways for Cell and Gene Therapies

Avalere

2:00

CHOOSE BETWEEN TWO TOPIC INTENSIVES (E-F)

E Payer Negotiations for Improved Profitability — A Role Play Exercise

Murray Kay
Former Senior Vice President and Chief Financial Officer
Solvay Pharmaceuticals;
Former Commercial Controller
AbbVie & Abbott Laboratories

FReimbursement Billing and Coding Strategies E and Considerations

2:45

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, AUGUST 13, 2019

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

8:45

STATE OF THE INDUSTRY Political and Legislative Trends Impacting Healthcare Coverage and Access

Christina Sandefur
Executive Vice President
Goldwater Institute

9:30

The Current State of Safe Harbor Protection for Rebates — Where Are We Now?

Ross Margulies
Associate
Foley Hoag LLP

10:15

Networking and Refreshment Break

10:45

PANEL Realign Access Strategies to Overcome Challenges of Copay Assistance and PBM Restrictions

PANELISTS:

Stacey Worthy
Counsel
Aimed Alliance

Kollet Koulianos, MBA
Senior Director, Payer Relations
National Hemophilia Foundation

Christina Simmons
Senior Corporate Counsel
Pfizer Inc

Saiza Elayda, J.D.
Director, State and Policy
PhRMA

11:30

COMPLIANCE SPOTLIGHT Trends in Enforcement and Oversight — What Companies Can Do to Ensure Compliance

PANELISTS:

Anthony Scicchitano
Assistant U.S. Attorney
U.S. Attorney’s Office for the Eastern District of Pennsylvania

Jacob Elberg
Associate Professor
Seton Hall University School of Law

12:15

Networking Luncheon

1:30

Outsource vs. Insource — Strategies and Considerations for Vendor Management

Colette Flack
Senior Director, Patient Support Services,
Dermira

2:15

PANEL Manufacturer Spotlight — Forward-Thinking Strategies to Ensure Market Access and Adherence

MODERATOR:

William Daniels
Director, Business and Market Segment Development
Conduent

PANELISTS:

Douglas Neely, CMPE
Head, Global Market Access
Athenex Oncology

Tony Tipton
Senior Director, Managed Markets and Trade Channels
Eyevance Pharmaceuticals

Gergana Zlateva
Vice President, Payer Insights and Access
Pfizer Inc

3:00

Networking and Refreshment Break

3:30 CHOOSE BETWEEN TWO SUMMITS (1-2)

1 Medicare and Marketplace Coverage Policies Impacting Access

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals;
former Director, Healthcare Policy and Federal Programs
BIO

2 Medical Device Coverage and Reimbursement

Timothy Kringel
Senior Vertical Solutions Consultant
LexisNexis Risk Solutions

4:30CHOOSE BETWEEN TWO SUMMITS (3-4)

3 New Product Commercialization/Launch
Scenario Planning

Jeff Henderson
Vice President, Head of Market Access and Government Affairs
Sobi, Inc.

Tami Carten
Executive Director, Market Access
Braeburn

4 Patient Assistance Compliance and Oversight

Rujul Desai
Of Counsel
Covington & Burling LLP

5:00

Close of Summits and Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO WEDNESDAY, AUGUST 14, 2019

8:00

Networking Breakfast

8:30

Conference Chairman’s Review of Day One

8:45

Changing Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and Pharmacy

Jesse C. Dresser, Esq.
Partner
Frier Levitt, LLC

9:30

Trends in Benefit Design and the Continued Shift to High Deductible Plans

Gregory Gierer
Senior Vice President, Policy
America’s Health Insurance Plans (AHIP)

Alex Keeton
Director, Policy Research and Analytics
BIO

10:15

Pathways to Improvement — Insight on Achieving a Value-Driven, Transparent and Affordable Healthcare System

J. Gabriel McGlamery, J.D.
Senior HCR Policy Consultant
Florida Blue

11:00

Networking and Refreshment Break

11:30

CHOOSE BETWEEN TWO TOPIC INTENSIVES (A-B)

A Paving the Way for Global Access and Commercialization

Stuart Bell
Vice President Consulting, Medicines Access
Inceptua Ltd

BBiosimilar Policy Evolution and Access Strategy

Molly Burich, MS
Director, Public Policy – Biosimilars and Reimbursement
Boehringer Ingelheim

12:15

Networking Luncheon

CHOOSE BETWEEN TWO TOPIC INTENSIVES (C-D)

C The Role and Growing Use of Digital Therapeutics by Payers, IDNs and Health Systems

Everett Crosland
Vice President, Market Access, Reimbursement and Government Affairs
AppliedVR

Andy Molnar
Senior Director, Market Access
Cognoa

DBuilding Value and Establishing Market Access C Pathways for Cell and Gene Therapies

Avalere

2:00

CHOOSE BETWEEN TWO TOPIC INTENSIVES (E-F)

E Payer Negotiations for Improved Profitability — A Role Play Exercise

Murray Kay
Former Senior Vice President and Chief Financial Officer
Solvay Pharmaceuticals;
Former Commercial Controller
AbbVie & Abbott Laboratories

FReimbursement Billing and Coding Strategies E and Considerations

2:45

Close of Conference